ICATIBANT IS A ?
**Core Concept**
Icatibant is a medication used in the management of acute attacks of **hereditary angioedema**. It works by inhibiting the action of **bradykinin**, a key mediator in the development of angioedema. This is achieved through its action as a selective **bradykinin B2 receptor antagonist**.
**Why the Correct Answer is Right**
Icatibant's mechanism of action involves competitive inhibition of the **bradykinin B2 receptor**, thereby preventing the increase in vascular permeability that leads to angioedema. By blocking this receptor, icatibant reduces the symptoms associated with hereditary angioedema, such as swelling of the face, extremities, and gastrointestinal tract. Its rapid onset of action makes it a valuable option for the treatment of acute attacks.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because icatibant is not primarily used for this purpose.
**Option B:** Incorrect as it does not accurately describe icatibant's mechanism.
**Option C:** Incorrect because icatibant is specifically used for hereditary angioedema, not other conditions.
**Clinical Pearl / High-Yield Fact**
Icatibant is administered subcutaneously and has a rapid onset of action, making it a useful treatment option for patients experiencing acute attacks of hereditary angioedema. Remember, icatibant is a **bradykinin receptor antagonist**, which distinguishes it from other treatments for angioedema.
**Correct Answer:** D. Bradykinin receptor antagonist.